OrbiMed’s Silverstein discloses Parkinson’s diagnosis, plans to stay in role


Photo of Jonathan Silverstein courtesy of Silverstein Foundation
Jonathan Silverstein, partner at healthcare investor OrbiMed Advisors, has been diagnosed with a rare form of Parkinson’s disease, but will continue full-time in his role as global co-head of private equity at the firm, he said in a letter to ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.

Digital Edition

VCJ august cover

To read a digital copy of our latest magazine

click here